BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

165 related articles for article (PubMed ID: 11959151)

  • 41. High expression of CD244 and SAP regulated CD8 T cell responses of patients with HTLV-I associated neurologic disease.
    Enose-Akahata Y; Matsuura E; Oh U; Jacobson S
    PLoS Pathog; 2009 Dec; 5(12):e1000682. PubMed ID: 19997502
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Immunopathogenesis of HTLV-1-assoaciated myelopathy/tropical spastic paraparesis (HAM/TSP).
    Fuzii HT; da Silva Dias GA; de Barros RJ; Falcão LF; Quaresma JA
    Life Sci; 2014 May; 104(1-2):9-14. PubMed ID: 24704970
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Presence of tropical spastic paraparesis/human T-cell lymphotropic virus type 1-associated myelopathy (TSP/HAM)-like among HIV-1-infected patients.
    Casseb J; de Oliveira AC; Vergara MP; Montanheiro P; Bonasser F; Meilman Ferreira C; Smid J; Duarte AJ
    J Med Virol; 2008 Mar; 80(3):392-8. PubMed ID: 18205234
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Role of Integrin Signaling Activation on the Development of Human T Cell Leukemia Virus-1 (HTLV-1)-Associated Myelopathy/Tropical Spastic Paraparesis: Its Relationship to HTLV-1-Infected CD4
    Nakamura T; Satoh K; Nakamura H; Fukushima N; Nishiura Y; Furuya T; Ichinose K
    AIDS Res Hum Retroviruses; 2018 Apr; 34(4):331-336. PubMed ID: 29400072
    [TBL] [Abstract][Full Text] [Related]  

  • 45. [Autoimmune syndrome in the tropical spastic paraparesis/myelopathy associated with human T-lymphotropic virus infections].
    Domínguez MC; Torres M; Tamayo O; Criollo W; Quintana M; Sánchez A; García F
    Biomedica; 2008 Dec; 28(4):510-22. PubMed ID: 19462556
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Association of CD40 ligand expression on HTLV-I-infected T cells and maturation of dendritic cells.
    Makino M; Utsunomiya A; Maeda Y; Shimokubo S; Izumo S; Baba M
    Scand J Immunol; 2001 Dec; 54(6):574-81. PubMed ID: 11902332
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Increased sialyl Lewis(x) antigen-positive cells mediated by HTLV-1 infection in peripheral blood CD4(+) T lymphocytes in patients with HTLV-1-associated myelopathy.
    Kambara C; Nakamura T; Furuya T; Nishiura Y; Kawakami A; Ichinose K; Shirabe S; Eguchi K
    J Neuroimmunol; 2002 Apr; 125(1-2):179-84. PubMed ID: 11960655
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Functional capacity of natural killer cells in HTLV-1 associated myelopathy/tropical spastic paraparesis (HAM/TSP) patients.
    Queiroz GAN; Mascarenhas REM; Vieillard V; Andrade RL; Galvão-Castro B; Grassi MFR
    BMC Infect Dis; 2019 May; 19(1):433. PubMed ID: 31101076
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Increased frequency of CD4+T cells expressing fractalkine receptor CX3CR1 in patients with HTLV-1 associated myelopathy/tropical spastic paraparesis (HAM/TSP), but its AIDS susceptible polymorphisms are not associated with the disease.
    Saito M; Usuku K; Arimura K; Izumo S; Osame M; Ohara Y
    J Neurol Sci; 2008 Mar; 266(1-2):13-9. PubMed ID: 17884099
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Antibody-dependent cell-mediated cytotoxicity (ADCC) in HTLV-I associated myelopathy/tropical spastic paraparesis (HAM/TSP).
    Fujihara K; Itoyama Y; Yu F; Kubo C; Goto I
    J Neurol Sci; 1996 Oct; 142(1-2):65-9. PubMed ID: 8902722
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Differential patterns of serum biomarkers of immune activation in human T-cell lymphotropic virus type I-associated myelopathy/tropical spastic paraparesis, and adult T-cell leukemia/lymphoma.
    Giusti RM; Maloney EM; Hanchard B; Morgan OS; Steinberg SM; Wachter H; Williams E; Cranston B; Fuchs D; Manns A
    Cancer Epidemiol Biomarkers Prev; 1996 Sep; 5(9):699-704. PubMed ID: 8877061
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Involvement of p38 MAPK signaling pathway in IFN-gamma and HTLV-I expression in patients with HTLV-I-associated myelopathy/tropical spastic paraparesis.
    Fukushima N; Nishiura Y; Nakamura T; Yamada Y; Kohno S; Eguchi K
    J Neuroimmunol; 2005 Feb; 159(1-2):196-202. PubMed ID: 15652420
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Differentiation of HAM/TSP from patients with multiple sclerosis infected with HTLV-I.
    Puccioni-Sohler M; Yamano Y; Rios M; Carvalho SM; Vasconcelos CC; Papais-Alvarenga R; Jacobson S
    Neurology; 2007 Jan; 68(3):206-13. PubMed ID: 17224575
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Immunological signature of the different clinical stages of the HTLV-1 infection: establishing serum biomarkers for HTLV-1-associated disease morbidity.
    Starling AL; Coelho-Dos-Reis JG; Peruhype-Magalhães V; Pascoal-Xavier MA; Gonçalves DU; Béla SR; Lambertucci JR; Labanca L; Souza Pereira SR; Teixeira-Carvalho A; Ribas JG; Trindade BC; Faccioli LH; Carneiro-Proietti AB; Martins-Filho OA
    Biomarkers; 2015; 20(6-7):502-12. PubMed ID: 26474234
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Frequent reversible membrane damage in peripheral blood B cells in human T cell lymphotropic virus type I (HTLV-I)-associated myelopathy/tropical spastic paraparesis (HAM/TSP).
    Furukawa Y; Bangham CR; Taylor GP; Weber JN; Osame M
    Clin Exp Immunol; 2000 May; 120(2):307-16. PubMed ID: 10792381
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Programmed death-1 (PD-1)/PD-1 ligand pathway-mediated immune responses against human T-lymphotropic virus type 1 (HTLV-1) in HTLV-1-associated myelopathy/tropical spastic paraparesis and carriers with autoimmune disorders.
    Kozako T; Yoshimitsu M; Akimoto M; White Y; Matsushita K; Soeda S; Shimeno H; Kubota R; Izumo S; Arima N
    Hum Immunol; 2011 Nov; 72(11):1001-6. PubMed ID: 21851845
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Interleukin 12-augmented T cell proliferation of peripheral blood mononuclear cells from HIV-seropositive individuals is associated with interleukin 12 receptor beta 2 upregulation.
    Jones ML; Young JM; Huang QR; Puls RL; Webber CA; Benson EM
    AIDS Res Hum Retroviruses; 2003 Apr; 19(4):283-92. PubMed ID: 12804004
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Human T cell lymphotropic virus type 1 (HTLV-1) proviral load of HTLV-associated myelopathy/tropical spastic paraparesis (HAM/TSP) patients according to new diagnostic criteria of HAM/TSP.
    Grassi MF; Olavarria VN; Kruschewsky Rde A; Mascarenhas RE; Dourado I; Correia LC; de Castro-Costa CM; Galvão-Castro B
    J Med Virol; 2011 Jul; 83(7):1269-74. PubMed ID: 21567429
    [TBL] [Abstract][Full Text] [Related]  

  • 59. In vivo fluctuation of Tax, Foxp3, CTLA-4, and GITR mRNA expression in CD4(+)CD25(+) T cells of patients with human T-lymphotropic virus type 1-associated myelopathy.
    Ramirez E; Cartier L; Rodriguez L; Alberti C; Valenzuela MA
    Braz J Med Biol Res; 2010 Nov; 43(11):1109-15. PubMed ID: 20945034
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Human T-cell lymphotropic virus type I (HTLV-I) proviral DNA viral load among asymptomatic patients and patients with HTLV-I-associated myelopathy/tropical spastic paraparesis.
    Montanheiro PA; Oliveira AC; Posada-Vergara MP; Milagres AC; Tauil C; Marchiori PE; Duarte AJ; Casseb J
    Braz J Med Biol Res; 2005 Nov; 38(11):1643-7. PubMed ID: 16258633
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.